Entity Name: | VANDA PHARMACEUTICALS INC. |
Jurisdiction: | FLORIDA |
Filing Type: | Foreign Profit |
Status: |
Active
The business entity is active. This status indicates that the business is currently operating and compliant with state regulations, suggesting a lower risk profile for lenders and potentially better creditworthiness. |
Date Filed: | 10 Dec 2013 (11 years ago) |
Document Number: | F13000005321 |
FEI/EIN Number |
03-0491827
Federal Employer Identification (FEI) Number assigned by the IRS. |
Address: | 2200 Pennsylvania Ave NW, Suite 300E, Washington, DC, 20037, US |
Mail Address: | 2200 Pennsylvania Ave NW, Suite 300E, Washington, DC, 20037, US |
Place of Formation: | DELAWARE |
Name | Role | Address |
---|---|---|
Williams Tim | Sr | 2200 Pennsylvania Ave NW, Washington, DC, 20037 |
Wijkstrom Joakim | Chie | 2200 Pennsylvania Ave NW, Washington, DC, 20037 |
Chrousos Phaedra | Director | 2200 Pennsylvania Ave NW, Washington, DC, 20037 |
Ward Anne S | Director | 2200 Pennsylvania Ave NW, Washington, DC, 20037 |
Mitchell Stephen R | Director | 2200 Pennsylvania Ave NW, Washington, DC, 20037 |
Moran Kevin | Chief Financial Officer | 2200 Pennsylvania Ave NW, Washington, DC, 20037 |
C T CORPORATION SYSTEM | Agent | - |
Event Type | Filed Date | Value | Description |
---|---|---|---|
CHANGE OF PRINCIPAL ADDRESS | 2024-04-11 | 2200 Pennsylvania Ave NW, Suite 300E, Washington, DC 20037 | - |
CHANGE OF MAILING ADDRESS | 2024-04-11 | 2200 Pennsylvania Ave NW, Suite 300E, Washington, DC 20037 | - |
Name | Date |
---|---|
ANNUAL REPORT | 2024-04-11 |
ANNUAL REPORT | 2023-03-22 |
ANNUAL REPORT | 2022-03-26 |
ANNUAL REPORT | 2021-04-23 |
ANNUAL REPORT | 2020-05-28 |
ANNUAL REPORT | 2019-03-22 |
ANNUAL REPORT | 2018-04-02 |
ANNUAL REPORT | 2017-04-05 |
ANNUAL REPORT | 2016-09-06 |
ANNUAL REPORT | 2015-04-27 |
Date of last update: 01 Apr 2025
Sources: Florida Department of State